Stryker reports $3.3B in Q2 sales, neurotechnology & spine segment experiences 19.4% uptick: 6 things to know

Written by Mackenzie Garrity | July 25, 2018 | Print  |

Stryker released its second quarter 2018 operating results.

Here are six things to know:

1. The company reported net sales of $3.3 billion in the second quarter, a 10.3 percent increase year-over-year.

2. Within its orthopedic segment, Stryker experienced an 7.6 percent increase year-over-year, reaching $1.2B in sales. The company's medsurg segment also saw a 8.9 percent increase year-over-year.

3. Stryker's neurotechnology and spine segment reported $600M in sales, a 19.4 percent increase year-over-year.

4. Stryker's earnings per share increased 15.5 percent to $1.19, compared to the same quarter last year.

5. The company reported net earnings of $452 million, a 15.6 percent increase year-over-year.

6. Stryker expects its adjusted net earnings per diluted share to sit between $7.22 and $7.27 at the end of the year.

More articles on devices and implants:
5 things to know about Aesculap Implant Systems
5 things to expect from Stryker's Q2 results
Sen. Todd Young calls on President Trump, Congress to end medical device tax — 6 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months